Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0923
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Tyrosine Kinase Signalling in Breast Cancer: ErbB Family Receptor Tyrosine Kinases

Breast Cancer Research
Cancer ResearchOncology
2000English

Drug-Induced Ubiquitylation and Degradation of ErbB Receptor Tyrosine Kinases: Implications for Cancer Therapy

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2002English

HER2-Targeted Hybrid Peptide That Blocks HER2 Tyrosine Kinase Disintegrates Cancer Cell Membrane and Inhibits Tumor Growth in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases

Journal of Cell Biology
MedicineCell Biology
2000English

Receptor Tyrosine Kinases (RTKs) in Breast Cancer: Signaling, Therapeutic Implications and Challenges

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1998English

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2004English

Dacomitinib (PF-00299804), an Irreversible Pan-Her Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

Exploring Receptor Tyrosine Kinases-Inhibitors in Cancer Treatments

Egyptian Journal of Medical Human Genetics
Genetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy